Laurel Wealth Advisors (California)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $434K | Sell |
5,226
-2,000
| -28% | -$166K | 0.04% | 393 |
|
|
2022
Q3 | $573K | Sell |
7,226
-57
| -0.8% | -$4.52K | 0.06% | 315 |
|
|
2022
Q2 | $541K | Sell |
7,283
-1,710
| -19% | -$127K | 0.06% | 337 |
|
|
2022
Q1 | $808K | Sell |
8,993
-6,285
| -41% | -$565K | 0.07% | 290 |
|
|
2021
Q4 | $1.71M | Sell |
15,278
-155
| -1% | -$17.4K | 0.13% | 156 |
|
|
2021
Q3 | $1.94M | Sell |
15,433
-1,108
| -7% | -$139K | 0.36% | 55 |
|
|
2021
Q2 | $2.24M | Sell |
16,541
-722
| -4% | -$97.7K | 0.29% | 86 |
|
|
2021
Q1 | $2.34M | Sell |
17,263
-1,413
| -8% | -$192K | 0.35% | 64 |
|
|
2020
Q4 | $2.63M | Buy |
18,676
+396
| +2% | +$55.7K | 0.39% | 60 |
|
|
2020
Q3 | $2.04M | Buy |
18,280
+1,051
| +6% | +$117K | 0.34% | 64 |
|
|
2020
Q2 | $1.93M | Buy |
17,229
+11
| +0.1% | +$1.23K | 0.35% | 71 |
|
|
2020
Q1 | $1.33M | Buy |
17,218
+3,850
| +29% | +$298K | 0.31% | 82 |
|
|
2019
Q4 | $1.27M | Sell |
13,368
-1,000
| -7% | -$95.1K | 0.21% | 124 |
|
|
2019
Q3 | $1.1M | Hold |
14,368
| – | – | 0.19% | 137 |
|
|
2019
Q2 | $1.26M | Sell |
14,368
-574
| -4% | -$50.3K | 0.28% | 99 |
|
|
2019
Q1 | $1.35M | Sell |
14,942
-1,711
| -10% | -$155K | 0.33% | 82 |
|
|
2018
Q4 | $1.19M | Sell |
16,653
-77
| -0.5% | -$5.52K | 0.35% | 76 |
|
|
2018
Q3 | $1.6M | Sell |
16,730
-1,380
| -8% | -$132K | 0.39% | 64 |
|
|
2018
Q2 | $1.72M | Sell |
18,110
-277
| -2% | -$26.4K | 0.46% | 54 |
|
|
2018
Q1 | $1.61M | Hold |
18,387
| – | – | 0.5% | 53 |
|
|
2017
Q4 | $1.56M | Sell |
18,387
-4,160
| -18% | -$353K | 0.45% | 61 |
|
|
2017
Q3 | $1.95M | Buy |
22,547
+7,022
| +45% | +$608K | 0.65% | 36 |
|
|
2017
Q2 | $1.2M | Buy |
+15,525
| New | +$1.2M | 0.43% | 72 |
|